ARVINAS INC (ARVN) — insider trading
Health Care · NASDAQ
ARVINAS INC (ARVN) has 18 reported SEC Form 4 insider transactions in our data, including 6 open-market sales among the most recent 18 (latest 2026-06-24).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-24 | Bain Linda | Director | Grant / award / vesting (derivative) | 22,714 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Bain Linda | Director | Grant / award / vesting | 15,527 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Cunningham Everett | Director | Grant / award / vesting (derivative) | 22,714 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Cunningham Everett | Director | Grant / award / vesting | 15,527 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Kennedy Edward Moore Jr. | Director | Grant / award / vesting (derivative) | 22,714 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Kennedy Edward Moore Jr. | Director | Grant / award / vesting | 15,527 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Morrison Briggs | Director | Grant / award / vesting (derivative) | 22,714 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Morrison Briggs | Director | Grant / award / vesting | 15,527 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Norwalk Leslie V | Director | Grant / award / vesting (derivative) | 22,714 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Norwalk Leslie V | Director | Grant / award / vesting | 15,527 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Smaldone Alsup Laurie | Director | Grant / award / vesting (derivative) | 22,714 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Smaldone Alsup Laurie | Director | Grant / award / vesting | 15,527 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Saik Andrew | Officer (Chief Financial Officer) | Open-market sale | 5,696 | $8.16 | $46.5K | Form 4 |
| 2026-06-17 | Cacace Angela M | Officer (Chief Scientific Officer) | Open-market sale | 2,576 | $7.60 | $19.6K | Form 4 |
| 2026-05-21 | Teel Randy | Director, Officer (President and CEO) | Open-market sale | 2,209 | $9.04 | $20.0K | Form 4 |
| 2026-05-11 | Cacace Angela M | Officer (Chief Scientific Officer) | Open-market sale | 9,657 | $9.94 | $96.0K | Form 4 |
| 2026-05-11 | Loomis David K | Officer (VP, Chief Accounting Officer) | Open-market sale | 1,919 | $9.94 | $19.1K | Form 4 |
| 2026-05-11 | Saik Andrew | Officer (Chief Financial Officer) | Open-market sale | 11,139 | $9.94 | $110.7K | Form 4 |
Ask the chat about ARVN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ARVINAS INC (ARVN).
Last updated 2026-06-24 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.